title: ABT-450 combined with ritonavir, in addition to ABT-333 and ribavirin: a race for an interferon-free regimen to cure HCV infection.
authors.affiliation: Hepatology Department, AP-HP, University Paris Diderot 7 and INSERM U773, CRB3, Beaujon Hospital, Clichy, France. Electronic address: tarik.asselah@bjn.aphp.fr.
authors.forename: Tarik
authors.initials: T
authors.lastname: Asselah
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*
chemical_list: D000998:Antiviral Agents; D011480:Protease Inhibitors; D012254:Ribavirin
keywords: Chronic hepatitis C; DAA; Direct-acting antivirals; NS5A inhibitors; PegIFN; RVR; Resistance; SVR; Safety; Sustained virological response; direct-acting antivirals; eRVR; extended rapid virological response; pegylated interferon; rapid virologic response; sustained virological response